Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

18,214 total articles

Announcement of Private Exchange Offer for Any and All of CSN Inova Ventures’ Outstanding 6.750% Senior Notes due 2028 and Consent Solicitation

Announcement of Private Exchange Offer for Any and All of CSN Inova Ventures’ Outstanding 6.750% Senior Notes due 2028 and Consent Solicitation

CSN's subsidiary, CSN Inova Ventures, initiates a private exchange offer for its outstanding 6.750% Senior Notes due 2028, allowing eligible holders to exchange these notes for new 11.000% Senior Notes due 2030 plus cash. The offer includes a consent solicitation for amendments to the 2028 notes indenture. Key conditions include a required minimum …

Telix H1 2026 Results: Investor Webcast Notification

Telix H1 2026 Results: Investor Webcast Notification

Telix Pharmaceuticals Limited will release its financial results for the half-year ended June 30, 2026, on August 20, 2026, accompanied by an investor webcast and conference call. The company is a commercial-stage global radiopharmaceutical firm focused on targeted theranostics for cancer treatment and diagnosis, with an established prostate cancer…

Replimune Announces Favorable Outcome of FDA's Cellular, Tissue, and Gene Therapies Advisory Committee Meeting for RP1 in Advanced Melanoma

Replimune Announces Favorable Outcome of FDA's Cellular, Tissue, and Gene Therapies Advisory Committee Meeting for RP1 in Advanced Melanoma

Replimune Group, Inc. announced a favorable outcome from the FDA's Cellular, Tissue, and Gene Therapies Advisory Committee regarding the Biologics License Application resubmission for RP1, an oncolytic immunotherapy, used in combination with nivolumab to treat advanced melanoma patients who progressed after prior anti-PD-1 therapy. The committee vo…

Sanuwave Will Host a Conference Call on August 7, 2026 at 8:30 AM (ET) to Present Q2 2026 Financial Results

Sanuwave Will Host a Conference Call on August 7, 2026 at 8:30 AM (ET) to Present Q2 2026 Financial Results

Sanuwave Health, Inc., a NASDAQ-listed company specializing in FDA-approved wound care and regenerative medicine products, announced it will host a conference call on August 7, 2026, to discuss its Q2 2026 financial results. The company focuses on developing non-invasive medical systems for tissue repair and regeneration across various medical fiel…

DBV Technologies Announces Sale of Approximately $50 Million of ADSs Through Its At-The-Market (ATM) Program on Nasdaq

DBV Technologies Announces Sale of Approximately $50 Million of ADSs Through Its At-The-Market (ATM) Program on Nasdaq

DBV Technologies, a late-stage biopharmaceutical company focused on treatments for food allergies, announced the sale of approximately $50 million in American Depositary Shares (ADSs) under its At-The-Market (ATM) equity offering program on Nasdaq. This issuance represents about 5.82% dilution to existing shareholders and aims to support clinical p…

Seer Confirms Receipt of Further Revised Unsolicited Acquisition Proposals From Radoff-JEC Group and From Omid Farokhzad, M.D.

Seer Confirms Receipt of Further Revised Unsolicited Acquisition Proposals From Radoff-JEC Group and From Omid Farokhzad, M.D.

Seer, Inc., a Nasdaq-listed proteomics company, announced receipt of further revised unsolicited acquisition proposals from both the Radoff-JEC Group and its CEO, Omid Farokhzad, for all outstanding shares priced around $2.45 to $2.55 per share plus contingent value rights. The Special Committee of Seer's Board will review these bids and other alte…

Trekor to Release Second Quarter 2026 Results

Trekor to Release Second Quarter 2026 Results

Trekor Metals Limited is scheduled to release its second quarter 2026 financial results on August 5, 2026, with a subsequent investor conference call and webcast on August 6, 2026. The event will allow analysts and investors to engage with management, but the press release provides no indication of expected performance outcomes or new developments.

Eldorado Gold Announces Renewal of Normal Course Issuer Bid

Eldorado Gold Announces Renewal of Normal Course Issuer Bid

Eldorado Gold Corporation announces the renewal of its normal course issuer bid (NCIB), allowing the company to repurchase up to 13,065,993 common shares over the next year. The move follows substantial repurchases under its previous NCIB and is driven by management's belief that the current market price undervalues the company's long-term potentia…

Eldorado Gold Announces Board Leadership Transition

Eldorado Gold Announces Board Leadership Transition

Eldorado Gold Corporation announced the completion of its Board of Directors leadership transition, with Dan Myerson appointed as Chair and Patrick Godin as Lead Independent Director. This change supports the company's ongoing succession plan as it advances significant growth projects such as Skouries and McIlvenna Bay. The transition aims to ensur…

Eldorado Gold Provides Update on Executive Leadership Transition

Eldorado Gold Provides Update on Executive Leadership Transition

Eldorado Gold Corporation confirms that George Burns will retire as CEO effective September 30, 2026, succeeded by Christian Milau. Other key executive leadership changes include legal and operational roles, aiming to ensure continuity and support the company’s growth strategy as it advances projects such as the Skouries mine. The transitions are p…

Soulpower Acquisition Corporation (NYSE:SOUL) and SWB Holdings Announce BVI Court Approval in Connection with Bank of Asia (BVI) Transaction

Soulpower Acquisition Corporation (NYSE:SOUL) and SWB Holdings Announce BVI Court Approval in Connection with Bank of Asia (BVI) Transaction

Soulpower Acquisition Corporation (NYSE: SOUL) and SWB Holdings announced the High Court of Justice of the Virgin Islands has approved the sale of certain Bank of Asia (BVI) Limited assets to SWB LLC. The transaction remains subject to additional conditions including regulatory approvals and shareholder consent for a business combination creating S…

Eldorado Gold Reports Solid Q2 2026 Financial and Operational Results; Skouries On Track for Q3 2026

Eldorado Gold Reports Solid Q2 2026 Financial and Operational Results; Skouries On Track for Q3 2026

Eldorado Gold Corporation reported solid financial and operational results for Q2 2026, with gold production of 104,616 ounces and revenues of $487.5 million. The Skouries project is 97% complete, on track for first concentrate production in Q3 2026 and commercial production in Q4. The McIlvenna Bay mine achieved first copper and zinc concentrate p…

HOME FEDERAL BANCORP, INC. OF LOUISIANA REPORTS RECORD ANNUAL EARNINGS AND RESULTS OF OPERATIONS FOR THE THREE MONTHS AND YEAR ENDED JUNE 30, 2026

HOME FEDERAL BANCORP, INC. OF LOUISIANA REPORTS RECORD ANNUAL EARNINGS AND RESULTS OF OPERATIONS FOR THE THREE MONTHS AND YEAR ENDED JUNE 30, 2026

Home Federal Bancorp, Inc. of Louisiana announced record annual earnings for the fiscal year ended June 30, 2026, with net income rising to $6.174 million, up from $3.888 million the prior year. The company improved key metrics including net interest margin, return on assets, and book value per share, supported by loan and deposit growth. The resul…

JIADE LIMITED Announces Resumption of Trading on Nasdaq

JIADE LIMITED Announces Resumption of Trading on Nasdaq

JIADE LIMITED announced that its halted trading on Nasdaq will resume on July 31, 2026, after the Nasdaq Staff completed its review regarding the company's recent trading activity, multiple share consolidations, and registered direct offerings. The company provided comprehensive responses and documentation alleviating Nasdaq's concerns. Both the 25…

STERIS Raises Dividend to $0.69 per share

STERIS Raises Dividend to $0.69 per share

STERIS plc declared a quarterly interim dividend of $0.69 per share, an increase of $0.06 from the previous dividend, continuing its 21-year streak of dividend growth. The dividend will be paid on September 25, 2026, to shareholders of record on September 4, 2026. The announcement underscores STERIS's strong financial position and commitment to sha…